Clinically relevant cancer biomarkers and pharmacogenetic assays (Q38077041)

28 August 2017

1 reference

title

Clinically relevant cancer biomarkers and pharmacogenetic assays (English)

1 reference

28 August 2017

0 references

Jai N Patel

1

1 reference

PubMed ID

23353710

28 August 2017

Katherine Mandock

series ordinal

2

1 reference

PubMed ID

23353710

28 August 2017

Howard L McLeod

series ordinal

3

1 reference

28 August 2017

24 January 2013

1 reference

Journal of Oncology Pharmacy Practice

28 August 2017

1 reference

28 August 2017

20

1 reference

28 August 2017

1

1 reference

28 August 2017

65-72

1 reference

Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges

28 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

DPYD*2A mutation: the most common mutation associated with DPD deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Part 1: background, methodology, and clinical adoption of pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Gene-expression assays: new tools to individualize treatment of early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Genomics and the continuum of cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

The cancer biomarker problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

The application of single nucleotide polymorphism microarrays in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

21 January 2018

Whole genome sequencing

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155212473862

21 January 2018

Identifiers

DOI

10.1177/1078155212473862

1 reference

28 August 2017

1 reference

PubMed ID

23353710